Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peixin Chen

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
Journal for Immunotherapy of Cancer|October 21, 2020
Galectin-9-based immune risk score model helps to predict relapse in stage I-III small cell lung cancerPeixin Chen, Liping Zhang, Wei Zhang, et al.
Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology|October 8, 2008
[High level expression, purification and characterization of human kallikrein-1 in Pichia pastoris]Xiudong Huang, Shusheng Wang, Peixin Chen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 8, 2025
Selective Depletion of CCR8+Treg Cells Enhances the Antitumor Immunity of Cytotoxic T Cells in Lung Cancer by Dendritic CellsPeixin Chen, Haowei Wang, Zhuoran Tang, et al.
Cell Death & Disease|September 26, 2023
YAP1 expression is associated with survival and immunosuppression in small cell lung cancerPeixin Chen, Chenglong Sun, Hao Wang, et al.
Frontiers in Public Health|April 10, 2024
Association of socioeconomic status and overactive bladder in US adults: a cross-sectional analysis of nationally representative dataWeilong Lin, Taibiao Li, Zhengyuan Xu, et al.
Frontiers in Genetics|November 17, 2022
Computational recognition of LncRNA signatures in tumor-associated neutrophils could have implications for immunotherapy and prognostic outcome of non-small cell lung cancerZhuoran Tang, Qi Wang, Peixin Chen, et al.
International Immunopharmacology|November 18, 2024
Machine learning identifies immune-based biomarkers that predict efficacy of anti-angiogenesis-based therapies in advanced lung cancerPeixin Chen, Lei Cheng, Chao Zhao, et al.
Translational Lung Cancer Research|March 15, 2021
The landscape of immune checkpoints expression in non-small cell lung cancer: a narrative reviewYu Liu, Peixin Chen, Hao Wang, et al.
Annals of Translational Medicine|November 4, 2021
Lymphocyte activation gene-3 is associated with programmed death-ligand 1 and programmed cell death protein 1 in small cell lung cancerHui Sun, Jiawei Dai, Lishu Zhao, et al.
Oncoimmunology|July 22, 2021
An immune-based risk-stratification system for predicting prognosis in pulmonary sarcomatoid carcinoma (PSC)Haoyue Guo, Binglei Li, Li Diao, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Journal for Immunotherapy of Cancer|October 21, 2020
Galectin-9-based immune risk score model helps to predict relapse in stage I-III small cell lung cancerPeixin Chen, Liping Zhang, Wei Zhang, et al.
Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology|October 8, 2008
[High level expression, purification and characterization of human kallikrein-1 in Pichia pastoris]Xiudong Huang, Shusheng Wang, Peixin Chen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 8, 2025
Selective Depletion of CCR8+Treg Cells Enhances the Antitumor Immunity of Cytotoxic T Cells in Lung Cancer by Dendritic CellsPeixin Chen, Haowei Wang, Zhuoran Tang, et al.
Cell Death & Disease|September 26, 2023
YAP1 expression is associated with survival and immunosuppression in small cell lung cancerPeixin Chen, Chenglong Sun, Hao Wang, et al.
Frontiers in Public Health|April 10, 2024
Association of socioeconomic status and overactive bladder in US adults: a cross-sectional analysis of nationally representative dataWeilong Lin, Taibiao Li, Zhengyuan Xu, et al.
Frontiers in Genetics|November 17, 2022
Computational recognition of LncRNA signatures in tumor-associated neutrophils could have implications for immunotherapy and prognostic outcome of non-small cell lung cancerZhuoran Tang, Qi Wang, Peixin Chen, et al.
International Immunopharmacology|November 18, 2024
Machine learning identifies immune-based biomarkers that predict efficacy of anti-angiogenesis-based therapies in advanced lung cancerPeixin Chen, Lei Cheng, Chao Zhao, et al.
Translational Lung Cancer Research|March 15, 2021
The landscape of immune checkpoints expression in non-small cell lung cancer: a narrative reviewYu Liu, Peixin Chen, Hao Wang, et al.
Annals of Translational Medicine|November 4, 2021
Lymphocyte activation gene-3 is associated with programmed death-ligand 1 and programmed cell death protein 1 in small cell lung cancerHui Sun, Jiawei Dai, Lishu Zhao, et al.
Oncoimmunology|July 22, 2021
An immune-based risk-stratification system for predicting prognosis in pulmonary sarcomatoid carcinoma (PSC)Haoyue Guo, Binglei Li, Li Diao, et al.
Pageof 7